Literature DB >> 33289793

Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome.

Vincent Probst1, Thomas Goronflot2, Soraya Anys3, Romain Tixier4, Jean Briand5, Pauline Berthome3, Olivier Geoffroy6, Nicolas Clementy7, Jacques Mansourati8, Laurence Jesel9, Jean-Marc Dupuis10, Paul Bru11, Florence Kyndt1, Matthieu Wargny2, Béatrice Guyomarch1, Aurélie Thollet1, Philippe Mabo5, Pierre-Antoine Gourraud2, Nathalie Behar5, Frédéric Sacher4, Jean-Baptiste Gourraud1.   

Abstract

AIMS : Risk stratification of sudden cardiac arrest (SCA) in Brugada syndrome (Brs) remains the main challenge for physicians. Several scores have been suggested to improve risk stratification but never replicated. We aim to investigate the accuracy of the Brs risk scores. METHODS AND RESULTS : A total of 1613 patients [mean age 45 ± 15 years, 69% male, 323 (20%) symptomatic] were prospectively enrolled from 1993 to 2016 in a multicentric database. All data described in the risk score were double reviewed for the study. Among them, all patients were evaluated with Shanghai score and 461 (29%) with Sieira score. After a mean follow-up of 6.5 ± 4.7 years, an arrhythmic event occurred in 75 (5%) patients including 16 SCA, 11 symptomatic ventricular arrhythmia, and 48 appropriate therapies. Predictive capacity of the Shanghai score (n = 1613) and the Sieira (n = 461) score was, respectively, estimated by an area under the curve of 0.73 (0.67-0.79) and 0.71 (0.61-0.81). Considering Sieira score, the event rate at 10 years was significantly higher with a score of 5 (26.4%) than with a score of 0 (0.9%) or 1 (1.1%) (P < 0.01). No statistical difference was found in intermediate-risk patients (score 2-4). The Shanghai score does not allow to better stratify the risk of SCA. CONCLUSIONS : In the largest cohort of Brs patient ever described, risk scores do not allow stratifying the risk of arrhythmic event in intermediate-risk patient. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Accuracy; Brugada syndrome; ICD; Risk score; Risk stratification; Sudden cardiac death

Year:  2021        PMID: 33289793     DOI: 10.1093/eurheartj/ehaa763

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

Review 1.  Pathogenesis and Management of Brugada Syndrome: Recent Advances and Protocol for Umbrella Reviews of Meta-Analyses in Major Arrhythmic Events Risk Stratification.

Authors:  Hasina Masha Aziz; Michał P Zarzecki; Sebastian Garcia-Zamora; Min Seo Kim; Piotr Bijak; Gary Tse; Hong-Hee Won; Paweł T Matusik
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

2.  Performance of Multiparametric Models in Patients With Brugada Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Hui-Ting Wei; Wei Liu; Yue-Rong Ma; Shi Chen
Journal:  Front Cardiovasc Med       Date:  2022-04-14

3.  Ajmaline-Induced Abnormalities in Brugada Syndrome: Evaluation With ECG Imaging.

Authors:  Luigi Pannone; Cinzia Monaco; Antonio Sorgente; Pasquale Vergara; Paul-Adrian Calburean; Anaïs Gauthey; Antonio Bisignani; Shuichiro Kazawa; Antanas Strazdas; Joerelle Mojica; Felicia Lipartiti; Maysam Al Housari; Vincenzo Miraglia; Sergio Rizzi; Dimitrios Sofianos; Federico Cecchini; Thiago Guimarães Osório; Gaetano Paparella; Robbert Ramak; Ingrid Overeinder; Gezim Bala; Alexandre Almorad; Erwin Ströker; Gudrun Pappaert; Juan Sieira; Pedro Brugada; Mark La Meir; Gian-Battista Chierchia; Carlo de Asmundis
Journal:  J Am Heart Assoc       Date:  2022-01-13       Impact factor: 6.106

4.  The year in cardiovascular medicine 2021: arrhythmias.

Authors:  Harry J G M Crijns; Prashantan Sanders; Christine M Albert; Pier D Lambiase
Journal:  Eur Heart J       Date:  2022-03-21       Impact factor: 35.855

5.  Predictors of late arrhythmic events after generator replacement in Brugada syndrome treated with prophylactic ICD.

Authors:  Federico Migliore; Nicolò Martini; Leonardo Calo'; Annamaria Martino; Giulia Winnicki; Riccardo Vio; Chiara Condello; Alessandro Rizzo; Alessandro Zorzi; Luigi Pannone; Vincenzo Miraglia; Juan Sieira; Gian-Battista Chierchia; Antonio Curcio; Giuseppe Allocca; Roberto Mantovan; Francesca Salghetti; Antonio Curnis; Emanuele Bertaglia; Manuel De Lazzari; Carlo de Asmundis; Domenico Corrado
Journal:  Front Cardiovasc Med       Date:  2022-07-22

Review 6.  Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?

Authors:  Domenico Corrado; Mark S Link; Peter J Schwartz
Journal:  Eur Heart J       Date:  2022-08-21       Impact factor: 35.855

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.